Unity Biotechnology Statistics

Total Valuation

UBX has a market cap or net worth of $16.91 million. The enterprise value is $22.89 million.

Market Cap	16.91M
Enterprise Value	22.89M

Important Dates

The last earnings date was Tuesday, April 22, 2025, after market close.

Earnings Date	Apr 22, 2025
Ex-Dividend Date	n/a

Share Statistics

UBX has 17.21 million shares outstanding. The number of shares has increased by 9.47% in one year.

Current Share Class	17.21M
Shares Outstanding	17.21M
Shares Change (YoY)	+9.47%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	1.90%
Owned by Institutions (%)	16.43%
Float	15.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-83.96
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.95

Current Ratio	1.95
Quick Ratio	1.87
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -231.27% and return on invested capital (ROIC) is -47.83%.

Return on Equity (ROE)	-231.27%
Return on Assets (ROA)	-38.89%
Return on Invested Capital (ROIC)	-47.83%
Return on Capital Employed (ROCE)	-130.44%
Revenue Per Employee	n/a
Profits Per Employee	-$1.72M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.16% in the last 52 weeks. The beta is 1.30, so UBX's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-33.16%
50-Day Moving Average	1.42
200-Day Moving Average	1.46
Relative Strength Index (RSI)	37.26
Average Volume (20 Days)	139,926

Short Selling Information

The latest short interest is 704,778, so 4.09% of the outstanding shares have been sold short.

Short Interest	704,778
Short Previous Month	639,936
Short % of Shares Out	4.09%
Short % of Float	4.44%
Short Ratio (days to cover)	3.50

Income Statement

Revenue	n/a
Gross Profit	-12.06M
Operating Income	-27.76M
Pretax Income	-27.86M
Net Income	-27.50M
EBITDA	-26.94M
EBIT	-27.76M
Earnings Per Share (EPS)	-$1.63

Full Income Statement

Balance Sheet

The company has $16.93 million in cash and $22.61 million in debt, giving a net cash position of -$5.67 million or -$0.33 per share.

Cash & Cash Equivalents	16.93M
Total Debt	22.61M
Net Cash	-5.67M
Net Cash Per Share	-$0.33
Equity (Book Value)	-205,000
Book Value Per Share	-0.01
Working Capital	8.58M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.04M
Capital Expenditures	n/a
Free Cash Flow	-22.04M
FCF Per Share	-$1.28

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.47%
Shareholder Yield	-9.47%
Earnings Yield	-159.78%
FCF Yield	-128.04%

Analyst Forecast

The average price target for UBX is $5.33, which is 442.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.33
Price Target Difference	442.44%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1